{"id":10623,"date":"2003-02-01T09:50:40","date_gmt":"2003-02-01T09:50:40","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=10623"},"modified":"2003-02-01T09:50:40","modified_gmt":"2003-02-01T09:50:40","slug":"medscape-conference-coverage-based-on-selected-sessions-at-the-6th-international-congress-on-drug-therapy-in-hiv-infection","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/10623","title":{"rendered":"Medscape conference coverage, based on selected sessions at the 6th International Congress on Drug Therapy in HIV Infection"},"content":{"rendered":"

17-21 November 2002, Glasgow, Scotland<\/p>\n

Resistance and response to subsequent treatment following virologic failure of tenofovir-based therapy<\/strong>
\nGraeme Moyle
\nhttp:\/\/www.medscape.com\/viewarticle\/446683<\/a><\/p>\n

Once-daily fosamprenavir\/ritonavir appears comparable to twice-daily nelfinavir<\/strong>
\nW. David Hardy
\nhttp:\/\/www.medscape.com\/viewarticle\/446684<\/a><\/p>\n

Efficacy of T-20 holds up across subgroups with varying demographics and disease status<\/strong>
\nW. David Hardy
\nhttp:\/\/www.medscape.com\/viewarticle\/446685<\/a><\/p>\n

Nelfinavir Is less effective but better tolerated than ritonavir in advanced disease<\/strong>
\nGraeme Moyle
\nhttp:\/\/www.medscape.com\/viewarticle\/446686<\/a><\/p>\n

Zidovudine is metabolized to stavudine triphosphate in human cells<\/strong>
\nGraeme Moyle
\nhttp:\/\/www.medscape.com\/viewarticle\/446687<\/a>
\nLevels of abacavir and lamivudine in semen<\/strong>
\nMike Youle
\nhttp:\/\/www.medscape.com\/viewarticle\/446688<\/a><\/p>\n

Cellular expression of multidrug transporters only modestly affects intracellular PI levels<\/strong>
\nGraeme Moyle
\nhttp:\/\/www.medscape.com\/viewarticle\/446689<\/a><\/p>\n

Lactic acid metabolism is affected both by baseline level and by HIV infection itself<\/strong>
\nW. David Hardy
\nhttp:\/\/www.medscape.com\/viewarticle\/446690<\/a><\/p>\n

Sexual transmission of hepatitis C<\/strong>
\nMike Youle
\nhttp:\/\/www.medscape.com\/viewarticle\/446691<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

17-21 November 2002, Glasgow, Scotland Resistance and response to subsequent treatment following virologic failure of tenofovir-based therapy Graeme Moyle http:\/\/www.medscape.com\/viewarticle\/446683 Once-daily fosamprenavir\/ritonavir appears comparable to twice-daily nelfinavir W. David Hardy http:\/\/www.medscape.com\/viewarticle\/446684 Efficacy of T-20 holds up across subgroups with varying …<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-10623","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/10623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=10623"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/10623\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=10623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=10623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=10623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}